The destiny of Ca²⁺ released by mitochondria

Abstract

Mitochondrial Ca²⁺ is known to regulate diverse cellular functions, for example energy production and cell death, by modulating mitochondrial dehydrogenases, inducing production of reactive oxygen species, and opening mitochondrial permeability transition pores. In addition to the action of Ca²⁺ within mitochondria, Ca²⁺ released from mitochondria is also important in a variety of cellular functions. In the last 5 years, the molecules responsible for mitochondrial Ca²⁺ dynamics have been identified: a mitochondrial Ca²⁺ uniporter (MCU), a mitochondrial Na⁺–Ca²⁺ exchanger (NCLX), and a candidate for a mitochondrial H⁺–Ca²⁺ exchanger (Letm1). In this review, we focus on the mitochondrial Ca²⁺ release system, and discuss its physiological and pathophysiological significance. Accumulating evidence suggests that the mitochondrial Ca²⁺ release system is not only crucial in maintaining mitochondrial Ca²⁺ homeostasis but also participates in the Ca²⁺ crosstalk between mitochondria and the plasma membrane and between mitochondria and the endoplasmic/sarcoplasmic reticulum.

Introduction

Mitochondria are crucial organelles in ATP production as well as in Ca²⁺ storage. They also serve as master switches determining cell fate on exposure to different stimuli [1–3]. Mechanisms of Ca²⁺ homeostasis in mitochondria have been extensively studied over the last half century, so the importance of mitochondrial Ca²⁺ in regulating mitochondrial functions is well recognized. Ca²⁺ enters mitochondria mainly via a mitochondrial Ca²⁺ uniporter, a protein known as MCU or CCDC109A [4, 5]. The characteristics and physiological and pathophysiological functions of this protein, and its associated proteins have been widely studied [6–8]. On the other hand, studies of the molecules responsible for Ca²⁺ release by mitochondria have just begun, although functional characterization of the release system started in the 1970s [9]. The mitochondrial Ca²⁺ release system mainly consists of an Na⁺–Ca²⁺ exchanger and an H⁺–Ca²⁺ exchanger. The molecule responsible for the former (NCLX) was identified in 2010 [10]. A possible molecular candidate for the latter (Letm1) was reported in 2009 [11], although this is still controversial.

It is now well understood that some mitochondria are in close contact with the plasma membrane and others with the endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR). Although the molecular mechanisms of tethering of mitochondria to the plasma membrane are not well understood, several tethering protein complexes involved in interactions between mitochondria and the ER/SR have been identified, and details of the molecular mechanisms have been reviewed [12, 13]. It is believed that these interactions are important in modulating a variety of cellular functions.

In this paper we review recent progress in the study of mitochondrial Ca²⁺ release system, specifically, interactions between mitochondria and the ER/SR and interactions between mitochondria and the plasma membrane, and discuss their physiological and pathophysiological significance, focusing on the destiny of Ca²⁺ released by mitochondria.

Physiological roles of Ca²⁺ in mitochondria and released by mitochondria

Mitochondrial Ca²⁺ regulates diverse cellular functions

It is now well accepted that mitochondrial Ca²⁺ is important in regulation of diverse cellular functions (Fig. 1). For example, an increase of mitochondrial Ca²⁺ activates three dehydrogenases in the mitochondrial matrix: pyruvate dehydrogenase, oxoglutarate dehydrogenase, and isocitrate dehydrogenase. As a result, the mitochondrial NADH-to-NAD ratio increases and, hence, flow of electrons down the respiratory chain increases, adjusting ATP synthesis to the increased ATP needs of a cell [14–16]. Mitochondrial Ca²⁺-mediated NADH oxidase activation may result in increased production of mitochondrial reactive oxygen species (ROS). In fact, an increase of mitochondrial Ca²⁺ has been reported to increase production of ROS in the heart and in neurons, resulting in impaired respiration and in cytotoxicity [17, 18]. Several studies have indicated that Ca²⁺ activates F1-Fo ATP synthase, balancing ATP utilization increased by Ca²⁺, and that it is probably the intra-mitochondrial Ca²⁺ which regulates F1-Fo ATP synthase, although this is still controversial [19, 20]. A large increase of mitochondrial Ca²⁺ results in opening of a non-specific pore called the mitochondrial permeability transition pore (PTP). PTP opening is followed by inner mitochondrial membrane depolarization, uncoupling of oxidative phosphorylation, and massive mitochondrial swelling, resulting in necrosis [1, 21–23]. PTP is also involved in apoptosis. Apoptosis-promoting factors, for example cytochrome c and pro-caspases, are released to the cytosol through PTP [24–26]. Furthermore, cardiac mitochondrial nitric oxide (NO) synthase is activated by mitochondrial Ca²⁺, contributing to NO-mediated cardioprotection against PTP opening [27]. Accordingly, mitochondrial Ca²⁺ is crucial in tuning a variety of mitochondrial and, thus, cellular functions.

Fig. 1.

Regulation of mitochondrial functions by mitochondrial Ca²⁺. Mitochondrial Ca²⁺ activates three dehydrogenases in the mitochondrial matrix: pyruvate dehydrogenase (PDHC), oxoglutarate dehydrogenase (OGDH), and isocitrate dehydrogenase (ICDH). ROS production is stimulated by increased mitochondrial Ca²⁺, possibly via increased NADH production. F1-Fo ATP synthase is activated by mitochondrial Ca²⁺, although this is still controversial. This regulatory activity contributes to energy homeostasis. PTP opening is activated by a large increase of mitochondrial Ca²⁺, resulting in the release of a variety of compounds from mitochondria, for example cytochrome c (cytc), pro-caspase, and Ca²⁺, leading to apoptosis or necrosis. CS citrate synthase, ACO aconitase, SCS succinyl-CoA synthase, SDH succinate dehydrogenase, FH fumarate hydratase, MDH malate dehydrogenase, SN F1-Fo ATP synthase, RR ruthenium red, MUni mitochondrial Ca²⁺ uniporter, mRyR mitochondrial RyR, mNCX mitochondrial Na⁺–Ca²⁺ exchanger, mHCX mitochondrial H⁺–Ca²⁺ exchanger

What is the source of the mitochondrial Ca²⁺? The location of the mitochondria within the cell seems important for mitochondrial Ca²⁺ uptake. Some mitochondria are located in proximity to the plasma membrane or the ER/SR. Ca²⁺ flowing through the plasma membrane or released from the ER/SR predominantly enters neighbouring mitochondria. In other words, there is Ca²⁺ crosstalk between mitochondria and the plasma membrane and between mitochondria and the ER/SR (Fig. 2). A substantial amount of the Ca²⁺ flowing through the plasma membrane or released by the ER/SR binds to cytosolic soluble Ca²⁺-binding proteins, for example calmodulin, troponin C, and calbindin. Of these, calmodulin is a ubiquitous protein well conserved across eukaryotes and Ca²⁺-bound calmodulin regulates a variety of cellular functions by binding to calmodulin-dependent kinase, calcineurin, plasma membrane Ca²⁺ ATPase, and the ryanodine receptor, among others [28]. Further information about these Ca²⁺-buffering proteins is available in a detailed review [29].

Fig. 2.

Ca²⁺ communication between mitochondria and the plasma membrane and between mitochondria and the ER/SR

Ca²⁺ crosstalk between mitochondria and the plasma membrane and between mitochondria and the ER/SR

Ca²⁺ enters cells via Ca²⁺ channels in the plasma membrane, for example the voltage-gated Ca²⁺ channel (VDCC) and the Ca²⁺ release-activated Ca²⁺ channel (CRAC) or store-operated Ca²⁺ channel. The Ca²⁺ which enters the cell is efficiently taken up by mitochondria located near the plasma membrane [30–33]. Lawrie et al. [30] found that after depletion of stored Ca²⁺, re-addition of extracellular Ca²⁺ evoked an increase in mitochondrial Ca²⁺ but not in cytoplasmic Ca²⁺ in human umbilical vein endothelial cell line ECV304, in which 14 % of mitochondria are located within 700 nm of the inner surface of the plasma membrane. They suggested that Ca²⁺ levels increase in microdomains beneath the plasma membrane, causing predominant Ca²⁺ uptake by mitochondria facing the microdomains. However, the contribution of the Ca²⁺ microdomains depends on cell type, because this phenomenon was not observed for a clone of a HeLa cell line, in which <6 % of mitochondria are located in the proximity of the plasma membrane. Park et al. [32] reported that store-operated Ca²⁺ influx via CRAC channels through the basolateral membrane led to predominant Ca²⁺ uptake by sub-plasmalemmal mitochondria in pancreatic acinar cells. These reports suggest Ca²⁺ communication, through plasma membrane Ca²⁺ channels, with mitochondria located in proximity to plasma membrane. Ca²⁺ communication in the opposite direction has also been suggested. Mitochondrial membrane depolarization suppressed store-operated Ca²⁺ entry in T lymphocytes and in rat basophilic leukaemia cells [34, 35]. Accordingly, bidirectional Ca²⁺ crosstalk between mitochondria and the plasma membrane is important in the regulation of cellular functions. As will be described below, the mitochondrial Na⁺-Ca²⁺ exchanger NCLX is involved in this Ca²⁺ crosstalk.

The ER/SR is major Ca²⁺ store within the cells. The ER/SR is located close to mitochondria, approximately 5–30 nm, and narrow interorganellar spaces exist between the organelles in a variety of cell types, including B lymphocytes and cardiomyocytes [36]. Figure 3 shows 3D-reconstructed confocal images of mitochondria and the ER/SR of cultured B lymphocytes and cardiomyocytes. The two organelles are located close to each other, although narrow interorganellar spaces are not visible. The close contact between mitochondria and the ER/SR is supported by tethering proteins, for example MIRO, DRP1, MFN2, and Mmm1/Mdm10/Mdm12/Mdm34 complex [12, 13]. Mitochondria–ER/SR communication is important for regulation of a variety of cellular processes, including lipid biosynthesis, mitochondrial division, and Ca²⁺ signalling [12, 37]. With regard to Ca²⁺, these narrow interorganellar spaces may serve to create Ca²⁺ level much higher than in the bulk cytosol, up to 9–50 μM [38, 39], enabling the mitochondrial Ca²⁺ uniporter, the Ca²⁺ affinity of which is relatively low, to transport enough Ca²⁺ into mitochondria. Several studies reported that an inositol 1,4,5-trisphosphate (IP₃) receptor of the ER and a voltage-dependent anion channel of the outer mitochondrial membrane are located in the mitochondria–ER region, creating a Ca²⁺ pathway from the ER to the mitochondria. This may aid regulation of energy metabolism and apoptosis in such cells as HeLa cells, CHO cells, fibroblasts, and yeast [40–42]. Ca²⁺ released from the ryanodine receptor (RyR) on the SR also accumulates in mitochondria of rat ventricular myocytes, indicating preferential coupling of Ca²⁺ transport from the SR to mitochondria [38]. It has been suggested that reverse Ca²⁺ movement, from mitochondria to the ER/SR, is important for refilling ER/SR Ca²⁺ after ligand stimulation of such cells as HeLa cells, endothelial cell line, and vascular smooth muscle cells, to minimize cytosolic Ca²⁺ elevation and to prevent depletion of ER/SR Ca²⁺ [43–45]. The crucial importance of NCLX in the movement of Ca²⁺ from mitochondria to the ER/SR was clearly demonstrated in our recent studies [46–48], as described below. The bidirectional Ca²⁺ crosstalk between mitochondria and the ER/SR is also important for regulating cellular functions.

Fig. 3.

Close location of mitochondria and the ER/SR in A20 B lymphocytes (a) and in HL-1 cardomyocytes (b). Cells were co-transfected with mitochondria-targeted pTagRFP-mito (red) and ER/SR-targeted cameleon D1ER (green). Images were acquired by use of a laser-scanning confocal microscope (LSM710, Carl Zeiss) with a ×63 oil objective lens, and 3D images were reconstructed by use of Imaris (Bitplane) (color figure online)

Taken together, Ca²⁺ crosstalk between mitochondria and the plasma membrane and between mitochondria and the ER/SR is important in controlling cellular functions. Understanding the roles of each molecule participating in the Ca²⁺ crosstalk is particularly important for fully understanding cellular physiological and pathophysiological functions.

Ca²⁺-transporting systems in mitochondria

Studies of mitochondrial Ca²⁺ dynamics started more than half a century ago. The existence of a respiration-dependent pathway of Ca²⁺ into isolated rat kidney mitochondria was reported in the early 1960s [49, 50]. In the 1970s, pathways of Ca²⁺ out of isolated rat heart mitochondria (Na⁺-dependent) and out of isolated rat liver mitochondria (Na⁺-independent and H⁺-dependent) were discovered [9, 51]. Since then, characteristics of mitochondrial Ca²⁺ dynamics have been extensively studied [1, 52–54].

The major pathways of Ca²⁺ uptake into and efflux out of mitochondria are summarized in Fig. 1. Ca²⁺ uptake into mitochondria is mainly mediated by a mitochondrial Ca²⁺ uniporter driven by a highly negative membrane potential (mitochondrial membrane potential ΔΨ is −150 to −180 mV) [55]. Another uptake system is a rapid uptake mode (RaM) which might contribute to mitochondrial Ca²⁺ uptake from fast cytosolic Ca²⁺ transients. A mitochondrial ryanodine receptor is also reported to mediate Ca²⁺ uptake into rat heart mitochondria. Details are available in other reviews [1, 52]. It was not until the 2010s that the identities of the molecules responsible for the mitochondrial Ca²⁺ uniport were revealed. A regulator of the Ca²⁺ uniporter, MICU, was discovered in 2010 before cloning of the mitochondrial Ca²⁺ uniporter [56]. MCU (or CCDC109A) was then discovered as a gene coding the mitochondrial Ca²⁺ uniporter [4, 5]. Very recently, characteristics of MCU knockout have been reported. Although MCU knockout in Trypanosoma brucei resulted in marked dysregulation of mitochondrial bioenergetics, causing autophagy and cell death [57], relatively minor alteration of basal energetics was observed for MCU knockout mice [58]. MCU and its regulators have been reviewed in detail elsewhere [7, 8].

Ca²⁺ efflux from mitochondria is mainly mediated by two saturable pathways, an Na⁺-dependent (Na⁺–Ca²⁺ exchanger; benzodiazepines and CGP-37157-sensitive) pathway and an Na⁺-independent (H⁺–Ca²⁺ exchanger; ruthenium red-insensitive) pathway. Under pathophysiological conditions in which the PTP opens, PTP functions as a Ca²⁺ transporter from mitochondria. In the sections below we describe, in detail, the two physiological pathways of mitochondrial Ca²⁺ release.

Mitochondrial Na⁺–Ca²⁺ exchanger

Biophysical properties of the mitochondrial Na⁺–Ca²⁺ exchanger

The mitochondrial Na⁺–Ca²⁺ exchanger was first discovered by Carafoli et al. [9] in 1974 in isolated rat heart mitochondria. This Na⁺–Ca²⁺ exchange activity is found in a wide variety of tissues and is dominant in the heart, brain, skeletal muscle, parotid gland, adrenal cortex, and brown fat [52, 59]. The Na⁺–Ca²⁺ exchanger is also present in liver, kidney, and lung mitochondria, although its activity is weak [60]. In tissues in which mitochondrial Na⁺–Ca²⁺ exchange activity is low, H⁺–Ca²⁺ exchange activity is of dominant importance in the release of Ca²⁺ from mitochondria [61].

One interesting characteristic of the mitochondrial Na⁺–Ca²⁺ exchanger, which is distinct from the plasmalemmal Na⁺–Ca²⁺ exchanger (NCX), is that Li⁺ can substitute for Na⁺ [9]. This unique characteristic contributed to identification of NCLX, a gene responsible for the mitochondrial Na⁺–Ca²⁺ exchanger, as will be described in the next section. The stoichiometry (ion-exchange ratio) and the electrogenicity of the mitochondrial Na⁺–Ca²⁺ exchanger were controversial, but it was believed to be electroneutral [62, 63]. Our group clearly demonstrated, by use of permeabilized rat ventricular myocytes, that the mitochondrial Na⁺–Ca²⁺ exchanger is voltage-dependent and electrogenic, which suggests the stoichiometry is >3Na⁺ for one Ca²⁺ [64]. We also predicted by computer simulation that the voltage dependence of the mitochondrial Na⁺–Ca²⁺ exchanger changes, the affinity becoming lower with mitochondrial membrane depolarization [64]. Because of these features, the mitochondrial Na⁺–Ca²⁺ exchanger dynamically changes the exchange mode (forward or reverse) and modulates the mitochondrial Ca²⁺ concentration in a manner dependent on cytosolic Na⁺ concentration and mitochondrial membrane potential. Recently, several molecules which may modulate the mitochondrial Na⁺–Ca²⁺ exchanger have been identified. Gandhi et al. [18] reported that a deficiency of a PINK1, a 581-amino-acid protein consisting of a mitochondrial targeting motif and a serine/threonine kinase domain homologous with that of the Ca²⁺/calmodulin family, causes impairment of mitochondrial Ca²⁺ efflux via the mitochondrial Na⁺–Ca²⁺ exchanger. Mutations in the PINK1 gene are known to cause autosomal recessive Parkinson’s disease [18]. Da Cruz et al. [65] showed that a stomatin-like protein 2 (SLP-2), a novel member of the stomatin superfamily found in several types of human tumour, negatively modulates mitochondrial Na⁺–Ca²⁺ exchange activity in HeLa cells, regulating the capacity of mitochondria to store Ca²⁺. Although detailed mechanisms underlying the regulation of mitochondrial Na⁺–Ca²⁺ exchange activity by these proteins have not yet been clarified, recent identification of NCLX as a mitochondrial Na⁺–Ca²⁺ exchanger will surely accelerate understanding of the mechanisms.

Cloning, tissue distribution, and cellular localization of NCLX

In 2004, two independent research groups reported the cloning of a new transporter mediating Na⁺–Ca²⁺ exchange, which was subsequently identified as a mitochondrial Na⁺–Ca²⁺ exchanger [66, 67]. Cai and Lytton employed a bioinformatics-based search of the GenBank™ database using a conserved amino acid sequence of the α-repeat regions of the K⁺-dependent Na⁺–Ca²⁺ exchanger (NCKX) gene family 2 (NCKX2) [66]. The amino acid sequence of the identified clone was divergent from that of NCX and NCKX family members, but was slightly closer to that of NCKX. The clone was therefore named “NCKX6”. They also found an alternative spliced isoform of mouse NCKX6. Although the long isoform was retained in the ER fraction and was not functional when heterologously expressed in HEK293 cells, the short isoform was targeted in the plasma membrane and had K⁺-dependent Na⁺–Ca²⁺ exchange activity. Very soon after the publication by Cai and Lytton [66], Sekler’s group found the same clone during a search for the Na⁺–Zn²⁺ exchanger gene [67]. In contrast with the report by Cai and Lytton [66], both long and short clones had K⁺-independent Na⁺–Ca²⁺ exchange activity and did not have Na⁺–Zn²⁺ exchange activity when heterologously expressed in HEK293 cells. They also found that Li⁺ can substitute for Na⁺ to release Ca²⁺ from the cells, so they named the clone “NCLX”. The discrepant results obtained by the two groups might be a result of different experimental conditions, i.e. Cai and Lytton [66] used Li⁺ as substituent for Na⁺ to examine K⁺-dependent Na⁺–Ca²⁺ exchange activity. This might have affected the responsiveness of the clone. In addition, FLAG epitope might have interfered with the sorting system in the Cai and Lytton [66] experiments. Anyway, both groups found that NCKX6/NCLX had Na⁺–Ca²⁺ exchange activity and broad tissue distribution, for example heart, pancreas, skeletal muscle, stomach, spleen, and brain.

It took another 6 years, however, for Sekler’s group to discover that NCKX/NCLX is the long-sought mitochondrial Na⁺–Ca²⁺exchanger. In 2010, Sekler’s group beautifully demonstrated that NCLX was located in mitochondria and its characteristics corresponded well to those of the mitochondrial Na⁺–Ca²⁺ exchanger [10]. Direct measurements of mitochondrial Ca²⁺ by use of the mitochondria-targeted Ca²⁺ sensing protein Pericam-mito [68] clearly showed that Ca²⁺ efflux from mitochondria was accelerated by overexpressing NCLX in an Na⁺ and Li⁺-dependent manner and was decelerated by knocking down NCLX. The fact that Li⁺ can substitute for Na⁺ in releasing Ca²⁺ from mitochondria corresponds well to the unique characteristic of mitochondrial Na⁺–Ca²⁺ exchange. This NCLX-mediated Ca²⁺ efflux from mitochondria was inhibited by the mitochondrial Na⁺–Ca²⁺ exchange inhibitor CGP-37157. It was also shown that mitochondrial Na⁺, measured by use of the mitochondrial Na⁺-sensing dye CoroNa Red, increased during the mitochondrial Ca²⁺ efflux phase, and the rate became much faster with NCLX overexpression. These results confirm that NCLX is the gene responsible for the mitochondrial Na⁺–Ca²⁺ exchanger. Since then, information about the involvement of NCLX in the physiological and pathophysiological functions of different types of cell has accumulated. We will describe, in detail, recent findings on the roles of NCLX in pancreatic β-cells, astrocytes, B lymphocytes, and cardiomyocytes. Experimental results from NCLX knockout/knockdown in each type of cell are summarized in Table 1.

Table 1.

Effects of NCLX reduction on cellular functions

	Mitochondrial Ca2+ at rest	Mitochondrial Ca2+ transient	Cytosolic Ca2+ transient	SOCE	ATP production	Others
Pancreatic β-cells ([70, 71])	Increased	Faster rise slower decline	Smaller	N.D.	Unchanged at steady state. Slightly accelerated during stimulation	Reduced insulin secretion
Astrocytes ([77])	Increased	Faster rise slower decline	Smaller	Smaller and slower	N.D.	Reduced glutamate release Impaired wound healing Impaired proliferation
B lymphocytes ([44, 45, 84])	N.D.	N.D.	Diminished cytosolic Ca2+ increase after BCR stimulation	Smaller and slower	N.D.	Increased apoptosis Reduced chemotaxis
Cardiomyocytes ([46, 102])	Increased	N.D.	Slower upstroke	N.D.	Unaffected	Cycle length prolongation

N.D. not determined

NCLX in pancreatic β-cells (Fig. 4a)

Fig. 4.

Roles of NCLX in pancreatic β-cells (a), astrocytes (b), B lymphocytes (c), and cardiomyocytes (d). See text for details

When the plasma glucose level increases, ATP production in pancreatic β-cells increases. ATP-dependent K⁺ channels consequently close, resulting in depolarization of the plasma membrane. Subsequently, voltage-gated Ca²⁺ channels open, causing Ca²⁺ influx into the cell, and exocytosis of insulin granules occurs [69]. In addition to the metabolic roles of mitochondria in the regulation of insulin secretion [70, 71], Tarasov et al. and Nita et al. [72, 73] demonstrated the contribution of NCLX to the function of pancreatic β-cells by use of the pancreatic β cell line MIN6 and mouse pancreatic primary β-cells. By use of pericam-mito to directly sense the mitochondrial Ca²⁺, Nita et al. [73] found that membrane depolarization-mediated Ca²⁺ influx, ATP-mediated ER Ca²⁺ depletion, and treatment with 20 mM glucose all caused a mitochondrial Ca²⁺ transient. In all cases, silencing of NCLX by use of siRNA or dominant negative mutant resulted in a more rapid increase in mitochondrial Ca²⁺ and slower mitochondrial Ca²⁺ decline. The resting mitochondrial Ca²⁺ level was higher in NCLX knockdown cells. These results not only suggest that NCLX functions as a mitochondrial Na⁺–Ca²⁺ exchanger, but also show that Ca²⁺ efflux via NCLX is already activated at the early phase of mitochondrial Ca²⁺ influx. Interestingly, silencing NCLX caused a smaller and slower cytosolic Ca²⁺ increase induced by membrane depolarization or by treatment with 20 mM glucose. Furthermore, NCLX knockdown was followed by a delay in glucose-dependent insulin secretion, whereas ATP production was little affected. These results indicate that NCLX is a critical component of the Ca²⁺ crosstalk between mitochondria and the plasma membrane in modulation of the insulin secretion pattern. Tarasov et al. obtained results essentially similar to those of Nita et al. [73] in repetitively depolarized MIN6 cells with regard to NCLX function. In addition, Tarasov et al. [72] found that glucose-induced mitochondrial Ca²⁺ response and subsequent ATP/ADP increase was impaired under the glucolipotoxic conditions often observed with type 2 diabetes. Because mRNA expression levels of MCU and NCLX were unaltered, it was suggested that changes in the intracellular distribution of mitochondria [74] were involved in this altered Ca²⁺ dysfunction and ATP production. In 2013, Proverbio et al. [75] used a multi-step screening strategy to identify genes related to congenital hyperinsulinism, characterized by severe hypoglycaemia as a result of inappropriate insulin secretion by pancreatic β-cells. They found a mutation in the NCLX-encoding SLC24A6 gene, which results in amino acid change at position 564 from tyrosine to histidine. Because this position resides in the middle of putative transmembrane domain 12 and is conserved among a variety of species, including chimpanzee, mouse, rat, cattle, chicken, and zebrafish, it is possible that the mutation causes a functional change of NCLX. Further analysis is required to clarify how NCLX is involved in the pathophysiological condition of pancreatic β-cells.

NCLX in astrocytes (Fig. 4b)

Brain is another tissue highly expressing NCLX. Among the different kinds of cell constituting the brain, astrocytes constitute approximately half the volume. They express a large number of G protein-coupled receptors (GPCRs), linked to a diverse array of intracellular cascades including elevation of intracellular Ca²⁺. It is also well known that astrocytes release neurotransmitters called gliotransmitters, for example glutamate, ATP and d-serine, which bind to neuronal receptors to modulate synaptic transmission and activity [76, 77]. Thus astrocytes not only interact with neuronal activity but also modulate this activity via gliotransmitters. Although still controversial, several reports suggest that release of gliotransmitters by astrocytes depends on elevation of cytosolic Ca²⁺ [77, 78]. The increase of cytosolic Ca²⁺ in astrocytes occurs via the phospholipase C (PLC)/IP₃ pathway. That is, upon GPCR activation, PLC hydrolyses the membrane lipid phosphatidylinositol 4,5-bisphosphate to generate diacylglycerol and IP₃, activating the IP₃ receptor (IP₃R) and releasing Ca²⁺ from the ER. Parnis et al. [79], by use of a mouse astrocyte culture, examined how NCLX is involved in Ca²⁺ dynamics and the release of gliotransmitters. They used pericam-mito to sense mitochondrial Ca²⁺ and found that the resting mitochondrial Ca²⁺ level increased, and that the rise and decline of mitochondrial Ca²⁺ transients caused by extracellular ATP application became faster and slower, respectively, on knocking down NCLX. These results were very similar to those observed for pancreatic β-cells [73]. Interestingly, NCLX knockdown reduced Ca²⁺ entry into the cytosol both from extracellular space and from the ER, but the effect on the former was stronger. Detailed analysis revealed that NCLX knockdown impairs store-operated Ca²⁺ entry (SOCE), indicative of strong Ca²⁺ crosstalk between mitochondria and the plasma membrane, as in pancreatic β-cells. NCLX knockdown also significantly reduced such processes as exocytotic glutamate release, in vitro wound closure, and proliferation, which may be regulated in a Ca²⁺-dependent manner [79].

NCLX in B lymphocytes (Fig. 4c)

Activation of B lymphocytes by antigens is followed by an increase in cytosolic Ca²⁺, resulting in rapid proliferation and differentiation or apoptosis, depending on the differentiation stage of the cells [80]. Upon binding of the antigen to the B cell surface receptor (BCR), IP₃ increases and facilitates Ca²⁺ release from the IP₃R on the ER membrane. Ca²⁺ release from the ER causes the initial cytosolic Ca²⁺ increase after receptor activation. Subsequent depletion of Ca²⁺ in the ER causes translocation of stromal interaction molecule 1 (STIM1) to the vicinity of plasmalemma, inducing a sustained and oscillatory cytosolic Ca²⁺ increase by activation of SOCE through CRAC channels encoded by ORAI1 [81, 82]. We discovered that NCLX is crucial in this antigen receptor -mediated Ca²⁺ signalling from a combined study of mathematical simulations and NCLX knockout/knockdown in DT40 and A20 B lymphocytes [46, 47]. NCLX reduction greatly reduced cytosolic Na⁺-dependent mitochondrial Ca²⁺ efflux in saponin-permeabilized cells loaded with the mitochondrial Ca²⁺-sensitive dye Rhod-2, confirming that NCLX is responsible for mitochondrial Na⁺–Ca²⁺ exchange in B lymphocytes. Interestingly, mitochondrial membrane potential, evaluated by JC-1 staining, was more depolarized and DNA fragmentation (sub G1) was increased in NCLX knockout cells, suggesting that the progress of apoptosis was accelerated in NCLX knockout cells. Mathematical model revealed that NCLX inhibition reduces basal ER Ca²⁺ content and suppresses BCR-mediated cytosolic Ca²⁺ rise. These predictions were validated by experiments. i.e., ER Ca²⁺ content decreased and the cytosolic increase of Ca²⁺ was diminished in NCLX knockout/knockdown cells after the BCR activation. Comparable with the results obtained by use of astrocytes, SOCE activity in B lymphocytes was also diminished by silencing NCLX, probably further contributing to impairment of the cytosolic Ca²⁺ increase after BCR activation [47]. The reduction in ER Ca²⁺ content was a result of impaired Ca²⁺ supply from mitochondria via NCLX, because ER Ca²⁺ uptake via the ER Ca²⁺ pump SERCA was decelerated by NCLX reduction when mitochondrial respiration was intact (Fig. 5a) whereas it was comparable when mitochondrial respiration was disturbed [47]. Interesting findings were that NCLX reduction resulted in impaired co-localization of mitochondria with ER and augmented ER Ca²⁺ leak. Although the cause remains unresolved, NCLX may be associated with the tethering proteins connecting ER and mitochondria [83, 84], and reduction of NCLX may weaken mitochondria–ER interactions. Alternatively, mitochondrial depolarization induced by NCLX knockout/knockdown might result in elimination of the impaired mitochondria by mitophagy [85]. Taken together, our results not only show that NCLX is involved in the crosstalk between mitochondria and the plasma membrane, as revealed by SOCE regulation, but also indicate that NCLX-mediated crosstalk between mitochondria and ER Ca²⁺ dynamics is crucial for physiological functioning of B lymphocytes; i.e. a response to BCR activation. Very recently we found that silencing NCLX reduced the chemotaxis of B lymphocytes triggered by chemokine CXCL12, although the mechanism is still unclear [86]. Although further analysis is needed, it is likely that NCLX is important in regulation of immune systems.

Fig. 5.

Modulation of SERCA activity by NCLX reduction in (a) DT40 B lymphocytes and (b) HL-1 cardiomyocytes. a ER Ca²⁺ uptake by wild type and NCLX^+/− DT40 cells. ER Ca²⁺ uptake were activated by applying 0.1 mM MgATP and 100 nM Ca²⁺ in Mag Fluo-4-loaded and permeabilized cells under conditions in which mitochondrial respiration was intact. The bar graph depicts the initial velocity of the ER Ca²⁺ increase. Data are mean ± SEM of independent recordings. Modified from Kim et al. [44]. b SR Ca²⁺ reuptake by HL-1 cardiomyocytes. Plasmid harbouring Cameleon D1ER, an indicator of SR Ca²⁺, was co-transfected with control (white) or NCLX siRNA (black) into HL-1 cardiomyoyctes. After emptying Ca²⁺ in SR with 10 mM caffeine, recovery of SR Ca²⁺ was measured. The bar graph depicts the recovery time constant τ, showing that SR Ca²⁺ reuptake was slower in NCLX knockdown cells. **p < 0.01, *p < 0.05. Modified from Takeuchi et al. [46]

NCLX in cardiomyocytes (Fig. 4d)

The heart is one of the most studied organs for investigation of the characteristics of the mitochondrial Na⁺–Ca²⁺ exchanger, which serves as a major Ca²⁺ release system [87, 88]. The roles of the mitochondrial Na⁺–Ca²⁺ exchanger in cardiac energetics have been widely investigated. For example, activation of the mitochondrial Na⁺–Ca²⁺ exchanger by increasing cytosolic Na⁺ causes a decrease of mitochondrial Ca²⁺, resulting in an imbalance in energy demand and supply or in an increase of ROS production [89, 90]. In contrast, the contribution of the mitochondrial Na⁺–Ca²⁺ exchanger to cytosolic Ca²⁺ transients and to action potential generation has been regarded as negligible, because the contribution of mitochondrial Ca²⁺ uptake to Ca²⁺ release from cardiomyocytes is as low as 1–2 % [91]. However, we recently discovered that NCLX participates in modulation of action potential configuration and in regulation of the automaticity of HL-1, a spontaneously beating cardiac cell line originating from mouse atrial myocytes [48]. The expression patterns of ion channels and transporters in HL-1 cells are similar to those in adult atrial myocytes, except that HL-1 cells highly express the T-type Ca²⁺ channel (I _CaT) and the hyperpolarization-activated cation channel (I _ha), which are known to be involved in the automaticity of cardiac pacemaker sinoatrial (SA) node cells [92–95]. NCLX reduction using siRNA reduced NCLX protein expression by ~50 %, resulting in a ~50 % reduction of the rate of cytosolic Na⁺-dependent mitochondrial Ca²⁺ efflux, confirming that NCLX is responsible for mitochondrial Na⁺–Ca²⁺ exchange in HL-1 cells. Mitochondrial Ca²⁺ content, evaluated as the Ca²⁺ chelation-responsive fraction of the intensity of mitochondrial Ca²⁺ sensor pCase12-mito, was larger in NCLX knockdown cells. Although beat-to-beat change of mitochondrial Ca²⁺ was not observed in HL-1 cells, the result indicated that NCLX contributes to the steady state mitochondrial Ca²⁺ content in intact HL-1 cells. Cellular energetics seemed to be unaffected by NCLX knockdown, because there were no differences in cellular ATP content, mitochondrial membrane potential, or mitochondrial ROS between control cells and NCLX knockdown cells. This may be because protein expression of NCLX knockdown using siRNA was reduced by 50 % only.

An interesting finding was that NCLX knockdown caused marked prolongation of the cycle length of spontaneous action potentials and Ca²⁺ transients [48]. Kinetic analysis of electrophysiological data and Ca²⁺ transients obtained by line scanning cells loaded with cytosolic Ca²⁺ indicator Fluo-4 revealed that NCLX knockdown slowed the upstrokes of both action potentials and cytosolic Ca²⁺ transients. SR Ca²⁺ dynamics, which is known to contribute to the upstroke of cytosolic Ca²⁺ transients, was evaluated by use of ER/SR Ca²⁺ FRET protein cameleon D1ER [96]. As a result, SR Ca²⁺ content of NCLX knockdown cells was smaller and SR Ca²⁺ reuptake rate was slower (Fig. 5b), suggesting that the NCLX reduction-mediated prolongation of cycle length is related to compromised SR Ca²⁺ dynamics. The mechanisms underlying the NCLX reduction-mediated prolongation of cycle length was further studied with a newly constructed mathematical model of HL-1 cells [48]. The HL-1 cell model well reproduces the spontaneous generation of action potentials and Ca²⁺ transients, and the prolongation of the cycle length induced by knocking down NCLX. The model analysis indicated that automaticity of HL-1 cells is determined by spontaneous Ca²⁺ leak from the SR. Simulation of NCLX reduction showed that Ca²⁺ supply from the mitochondria to the SR decreased to slow down the rate of spontaneous Ca²⁺ leak from the SR. The timing of Ca²⁺-induced Ca²⁺ release (CICR), activation of the inward current of the plasma membrane NCX (I _NCX), and thus the timing of activation of voltage-dependent Na⁺ current (I _Na) and voltage-dependent T and L type Ca²⁺ channels (I _CaT and I _CaL) was thus delayed, resulting in prolongation of the cycle length. Taken together, our combined experiments and simulations indicated that NCLX regulates the rhythmicity of HL-1 cells via crosstalk between mitochondria and SR Ca²⁺ dynamics. Considering that NCLX reduction resulted in modification of plasma membrane NCX activity, NCLX may also be indirectly involved in mitochondria–plasma membrane Ca²⁺ crosstalk in HL-1 cells. Interestingly, Opuni and Reeves reported the functional coupling of mitochondrial function, possibly mitochondrial Na⁺–Ca²⁺ exchange activity, and plasma membrane NCX activity in Chinese hamster ovary cells stably transfected with bovine cardiac NCX [97]. Further analysis is necessary to elucidate the interaction of mitochondrial NCLX and plasma membrane NCX. Because HL-1 cells are derived from atrial myocytes, which have no automaticity under physiological conditions, NCLX may be involved in the abnormal automaticity of atria, for example atrial flutter or atrial ectopic tachycardia. It may also be possible that occurrence of arrhythmia in patients with mitochondrial disease [98, 99] is caused by abnormal NCLX function. Further analysis is required to clarify the involvement of NCLX in these arrhythmias.

Whether NCLX participates in the automaticity of normal pacemaker cells, sinoatrial (SA) node cells, is a big issue. Recently, Yaniv et al. [100] reported that mitochondrial Na⁺–Ca²⁺ exchange inhibitor CGP-37157 slowed the generation of automaticity of rabbit SA node cells, suggesting that mitochondrial Na⁺–Ca²⁺ exchange is involved in generation of the automaticity of SA node cells. However, because CGP-37157 also blocks I _CaL, which is related to generation of the automaticity of SA node cells, a nonspecific effect of CGP-37157 on I _CaL cannot be ignored. In addition, the automaticity of the SA node cells they used significantly depends on spontaneous and local subsarcolemmal Ca²⁺ releases from SR, the so called “Ca²⁺ clock” mechanism [101]. However, this automaticity mechanism has been controversial. It has been accepted for a long time that I _ha and a variety of other inward membrane currents determine the automaticity [102–104]. This mechanism is called the “membrane clock”. Whether NCLX contributes to the automaticity of all types of SA node cells, including the cells driven by “membrane clock”, must be studied.

We examined the contribution of NCLX using mathematical models of SA node cells [105]. In the original SA node model developed by Yaniv et al. [100], complete reduction of mitochondrial Na⁺–Ca²⁺ exchange resulted in prolongation of cycle length by 2.7 % only. The larger effect reported by Yaniv et al. [100] is probably because of their simultaneous reduction of the amplitude factor of SERCA. To further test the contribution of NCLX to generation of the automaticity of SA node cell models, we incorporated our model of mitochondrial Ca²⁺ dynamics into two representative SA node cell models: a membrane clock model by Himeno et al. [102, 103] and a Ca²⁺ clock model by Maltsev and Lakatta [101]. In both models, NCLX reduction reduced the SR Ca²⁺ content, supporting the idea of Ca²⁺ communication between mitochondria and the SR in SA node cells. However, the effect on the automaticity was different between the models. The cycle length was prolonged in the Maltsev and Lakatta model whereas it was shortened in the Himeno model [105]. Furthermore, model analysis revealed that cytosolic Na⁺ and Na⁺-permeable inward current (sustained inward current I _st) [106] are crucial factors distinguishing the effect of NCLX on pace-making in the two models. In the Himeno model, NCLX reduction reduced cytosolic Ca²⁺, which decreased the inward I _NCX thus reducing the cytosolic Na⁺ concentration. This increased the amplitude of the inward I _st and overcame the decrease of inward I _NCX, accelerating the firing rate. In contrast, the amplitude of I _st is set smaller in the Maltsev and Lakatta model so that NCLX reduction only reduces inward I _NCX and slows diastolic depolarization, decelerating the firing rate [105]. Accordingly, it is likely that the Ca²⁺ communication between mitochondria and the SR via NCLX functions also in SA node cells. However, it is necessary to investigate quantitatively how much the ‘‘Ca²⁺ clock’’ mechanism, cytoplasmic Na⁺, and I _st contribute to SA node automaticity.

Mitochondrial H⁺–Ca²⁺ exchanger

H⁺–Ca²⁺ exchange has a dominant effect on release of Ca²⁺ from mitochondria in tissues in which mitochondrial Na⁺–Ca²⁺ exchange activity is low, for example the liver, kidney, lung, and smooth muscle [61]. The H⁺–Ca²⁺ exchanger also occurs in the heart, though the activity is weak [61, 107].

The stoichiometry of the H⁺–Ca²⁺ exchanger is regarded as 2H⁺ for 1Ca²⁺, being electroneutral. However, because the rate of efflux via the H⁺–Ca²⁺ exchanger decreases with increasing pH gradient in rat isolated liver mitochondria, it is suggested that the mechanism is not a passive Ca²⁺ for 2H⁺ exchanger, but an active Ca²⁺ for 2H⁺ exchanger [108].

The molecular identity of the mitochondrial H⁺–Ca²⁺ exchanger is still controversial. The candidate is the Letm1 (leucine–zipper–EF hand-containing transmembrane region). Jiang et al. [11] conducted high-throughput RNA interference screening of Drosophila genes and identified a gene affecting mitochondrial Ca²⁺ and H⁺, the human homolog of which is Letm1. By using digitonin-permeabilized S2 or 293 cells expressing mitochondrial Ca²⁺ sensor protein pericam, or by using purified Letm1 reconstituted in liposomes, they found that Letm1 mediates H⁺–Ca²⁺ exchange. However, because a drastic reduction of mitochondrial Ca²⁺ uptake was observed when Letm1 protein expression was suppressed, and because H⁺–Ca²⁺ exchange via Letm1 was sensitive to an inhibitor of mitochondrial Ca²⁺ influx, ruthenium red, Letm1 is regarded as mediating Ca²⁺ influx into mitochondria, at least at low cytosolic Ca²⁺ level. This idea was confirmed by subsequent work by Jiang et al. [109] in which Letm1 knockdown in 293 cells resulted in dramatically reduced mitochondrial Ca²⁺ content. In the same work they produced Letm1 knockout mice and found that Letm1 homozygous knockout mice were embryonic lethal and so were half of the heterozygous knockout mice. The surviving mice had altered glucose metabolism, impaired control of brain ATP levels, and increased seizure activity, suggesting involvement of Letm1 in the pathology of Wolf–Hirschhorn syndrome, in which Letm1 is known to be one of the genes deleted [110]. Nowikovsky et al. [111] analysed theoretically the direction of Ca²⁺ flux through the mitochondrial membrane in energized mitochondria with different H⁺:Ca²⁺ stoichiometry. They proposed that Ca²⁺ enters mitochondria with 1H⁺:1Ca²⁺ whereas Ca²⁺ leaves mitochondria with 2H⁺:1Ca²⁺ or 3H⁺:1Ca²⁺ stoichiometry under physiological respiration conditions. Tsai et al. [112] reported that Letm1 mediates the electroneutral 2H⁺:1Ca²⁺ antiport and is insensitive to ruthenium red, by using Letm1 reconstituted proteoliposome. These results combined with the theoretical analysis by Nowikovsky et al. [111] strongly suggest that Letm1 is the long-awaited molecular identity of the mitochondrial H⁺–Ca²⁺ exchanger. There is, currently, no reasonable explanation of the discrepancy of the sensitivity of Letm1 to ruthenium red. We independently found that a substantial part of the Ca²⁺ efflux from mitochondria was independent of cytosolic Na⁺ when mitochondria were loaded with a lower concentration of Ca²⁺ than when examining Na⁺–Ca²⁺ exchange activity using A20 B lymphocytes [46]. This fraction, which probably represents the H⁺–Ca²⁺ exchange system, was sensitive to ruthenium red. Further analysis is necessary to determine whether Letm1 is, indeed, the H⁺–Ca²⁺ exchanger mediating Ca²⁺ extrusion from mitochondria.

Summary

Ca²⁺, not only inside mitochondria but also released from mitochondria, is crucially important in regulating a variety of cellular physiological functions. Identification of the molecules responsible for the pathways of Ca²⁺ release enables us to isolate the contributions of these molecules. For example, NCLX has been shown to participate in insulin secretion in pancreatic β-cells, glutamate release in astrocytes, Ca²⁺ responsiveness to BCR stimulation in B lymphocytes, and generation of the spontaneous rhythmicity of cadiomyocytes, via Ca²⁺ crosstalk between mitochondria and the plasma membrane and/or between mitochondria and the ER/SR (Fig. 4). However, many issues remain unanswered. One is the question of whether mitochondrial Ca²⁺ release proteins are indeed located in the tethering spots between mitochondria and the ER/SR or between mitochondria and the plasma membrane. Another is the contribution of the mitochondrial Ca²⁺ release system to mitochondrial energetics. Distinct phenotypes of NCLX knockdown cells related to mitochondrial energetics in cardiomyocytes and in pancreatic β-cells have not been observed, while Letm1 knockout mice had impaired mitochondrial energetics. Complete knockout of NCLX in mice or cells will clarify the matter.